Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile.
Olaitan AO, Dureja C, Youngblom MA, Topf MA, Shen WJ, Gonzales-Luna AJ, Deshpande A, Hevener KE, Freeman J, Wilcox MH, Palmer KL, Garey KW, Pepperell CS, Hurdle JG. Olaitan AO, et al. Among authors: deshpande a. Nat Commun. 2023 Jul 12;14(1):4130. doi: 10.1038/s41467-023-39429-x. Nat Commun. 2023. PMID: 37438331 Free PMC article.
Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection.
Gonzales-Luna AJ, Olaitan AO, Shen WJ, Deshpande A, Carlson TJ, Dotson KM, Lancaster C, Begum K, Alam MJ, Hurdle JG, Garey KW. Gonzales-Luna AJ, et al. Among authors: deshpande a. Open Forum Infect Dis. 2021 Jul 8;8(8):ofab365. doi: 10.1093/ofid/ofab365. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34381844 Free PMC article.
Bacterial persister cells tackled.
Hurdle JG, Deshpande A. Hurdle JG, et al. Among authors: deshpande a. Nature. 2018 Apr 5;556(7699):40-41. doi: 10.1038/d41586-018-03440-w. Nature. 2018. PMID: 29620744 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 32099208
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron Variant of SARS-CoV-2.
Pandey K, Acharya A, Pal D, Jain P, Singh K, Durden DL, Kutateladze TG, Deshpande AJ, Byrareddy SN. Pandey K, et al. Among authors: deshpande aj. Antiviral Res. 2024 May 8:105904. doi: 10.1016/j.antiviral.2024.105904. Online ahead of print. Antiviral Res. 2024. PMID: 38729306
1,615 results